{"schema":"hottub-news/story/v1","story":"st_cxeaggv2mk6jarsf5lpq","title":"EQS-News: Biocons Pertuzumab erhält Marktzulassung in der EU - Erstes Biosimilar, das im Rahmen des neuen, fokussierten klinischen Ansatzes der EMA zugelassen wurde","title_en":"EQS-News: Biocons Pertuzumab receives market approval in the EU - First biosimilar approved under the EMA's new, focused clinical approach","outlets":3,"brief":null,"page":"https://hottub.news/stories/biocons-pertuzumab-gets-marketing-authorization-in-eu-first-biosimilar-cxeaggv2mk","count":4,"items":[{"id":"n_ekbvb7quw46n4glki3hq","seq":12523810,"kind":"article","title":"EQS-News: Biocons Pertuzumab erhält Marktzulassung in der EU - Erstes Biosimilar, das im Rahmen des neuen, fokussierten klinischen Ansatzes der EMA zugelassen wurde","title_en":"EQS-News: Biocons Pertuzumab receives market approval in the EU - First biosimilar approved under the EMA's new, focused clinical approach","url":"https://www.finanznachrichten.de/nachrichten-2026-11/70167762-eqs-news-biocons-pertuzumab-erhaelt-marktzulassung-in-der-eu-erstes-biosimilar-das-im-rahmen-des-neuen-fokussierten-klinischen-ansatzes-der-ema-zu-022.htm","published":"2026-11-18T15:21:00Z","seen":"2026-11-18T15:53:05Z","lang":"de","country":"DE","source":{"id":"finanznachrichten.de","name":"finanznachrichten.de","domain":"finanznachrichten.de","outlet":{"wikidata":"Q1408247","name":"Finanznachrichten.de","type":"website","designations":["website"]}},"via":"gdelt-gkg-translingual","topics":["economy","health"],"authors":["EQS Group (DE)"],"entities":[{"id":"Q8977","name":"East Midlands Airport","type":"org"}],"story":"st_cxeaggv2mk6jarsf5lpq","category":"health","category_p":0.3499999940395355,"category2":"economy-business","sentiment":"positive","tone":0.20000000298023224,"political":0.07999999821186066},{"id":"n_mm4ydohuwbcrwduqtyta","seq":12505147,"kind":"article","title":"Biocon's Pertuzumab Receives Marketing Authorization in EU, First Biosimilar Authorized Under EMA's New Tailored Clinical Approach","url":"https://www.finanznachrichten.de/nachrichten-2026-11/70166972-biocon-s-pertuzumab-receives-marketing-authorization-in-eu-first-biosimilar-authorized-under-ema-s-new-tailored-clinical-approach-008.htm","published":"2026-11-18T14:24:00Z","seen":"2026-11-18T15:06:42Z","lang":"en","country":"DE","source":{"id":"finanznachrichten.de","name":"finanznachrichten.de","domain":"finanznachrichten.de","outlet":{"wikidata":"Q1408247","name":"Finanznachrichten.de","type":"website","designations":["website"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"authors":["PR Newswire"],"entities":[{"id":"Q487694","name":"Biocon","type":"org"},{"id":"Q1998021","name":"pertuzumab","type":"other"},{"id":"Q458","name":"European Union","type":"place"},{"id":"Q130146","name":"European Medicines Agency","type":"org"}],"story":"st_cxeaggv2mk6jarsf5lpq","category":"health","category_p":0.38999998569488525,"category2":"economy-business","sentiment":"positive","tone":0.20999999344348907,"political":0.07999999821186066},{"id":"n_2jy5dreypqi27xmsoopq","seq":12522938,"kind":"article","title":"El pertuzumab de Biocon recibe la autorización de comercialización en la UE. Primer biosimilar autorizado mediante el nu","url":"https://www.europapress.es/comunicados/internacional-00907/noticia-comunicado-pertuzumab-biocon-recibe-autorizacion-comercializacion-ue-primer-biosimilar-autorizado-nu-20261118152217.html","published":"2026-11-18T14:22:00Z","seen":"2026-11-18T15:53:05Z","lang":"es","country":"ES","source":{"id":"europapress.es","name":"europapress.es","domain":"europapress.es","outlet":{"wikidata":"Q3060712","name":"Europa Press","type":"news_agency","country":"ES","designations":["news agency"]}},"via":"gdelt-gkg-translingual","topics":["economy","science","health"],"story":"st_cxeaggv2mk6jarsf5lpq","category":"economy-business","category_p":0.4300000071525574,"category2":"science-technology","sentiment":"positive","tone":0.1899999976158142,"political":0.12999999523162842},{"id":"n_cxeaggv2mk6jarsf5lpq","seq":12358761,"kind":"article","title":"Biocon's Pertuzumab Gets Marketing Authorization in EU, First Biosimilar Approved Under New Tailored Clinical Approach","url":"https://www.equitybulls.com/news/379202/biocon-s-pertuzumab-gets-marketing-authorization-eu-first","published":"2026-11-18T06:23:00Z","seen":"2026-11-18T07:19:04Z","lang":"en","source":{"id":"equitybulls.com","name":"equitybulls.com","domain":"equitybulls.com"},"via":"gdelt-gkg-english","topics":["health","economy"],"authors":["Equity Bulls"],"story":"st_cxeaggv2mk6jarsf5lpq","category":"economy-business","category_p":0.33000001311302185,"category2":"health","sentiment":"positive","tone":0.3499999940395355,"political":0.05999999865889549}]}